CAMLINFINE103.71

Camlin Fine Sciences Limited

· Chemicals
₹ CrorePeersCLEANDEEPAKNTRBAYERCROPTIRUMALCHMATULSHKPAUSHAKLTDANURASMcap ₹1,992 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt657.7645.6668.1668.1
Net Debt577.4503.6559.5559.5
Total Debt/Equity0.770.740.670.67
Net Debt/Equity0.670.580.560.56
Total Debt/EBITDA8.903.106.256.25
Net Debt/EBITDA7.812.425.246.51
Interest Coverage (EBIT/Interest)-0.081.440.490.49
Total Debt/Total Capital %43.4242.4640.0340.03
As Filed — company-reported covenants
Debt/Equity (as filed)72.00
Debt Service Coverage (as filed)1.00
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.